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E-mail address: gv2131@columbia.edu (G. Vunjak-Silk ﬁbroin is a potent alternative to other biodegradable biopolymers for bone tissue engineering (TE),
because of its tunable architecture and mechanical properties, and its demonstrated ability to support
bone formation both in vitro and in vivo. In this study, we investigated a range of silk scaffolds for bone
TE using human adipose-derived stem cells (hASCs), an attractive cell source for engineering autologous
bone grafts. Our goal was to understand the effects of scaffold architecture and biomechanics and use this
information to optimize silk scaffolds for bone TE applications. Silk scaffolds were fabricated using differ-
ent solvents (aqueous vs. hexaﬂuoro-2-propanol (HFIP)), pore sizes (250–500 lm vs. 500–1000 lm) and
structures (lamellar vs. spherical pores). Four types of silk scaffolds combining the properties of interest
were systematically compared with respect to bone tissue outcomes, with decellularized trabecular bone
(DCB) included as a ‘‘gold standard’’. The scaffolds were seeded with hASCs and cultured for 7 weeks in
osteogenic medium. Bone formation was evaluated by cell proliferation and differentiation, matrix pro-
duction, calciﬁcation and mechanical properties. We observed that 400–600 lm porous HFIP-derived silk
ﬁbroin scaffold demonstrated the best bone tissue formation outcomes, as evidenced by increased bone
protein production (osteopontin, collagen type I, bone sialoprotein), enhanced calcium deposition and
total bone volume. On a direct comparison basis, alkaline phosphatase activity (AP) at week 2 and new
calcium deposition at week 7 were comparable to the cells cultured in DCB. Yet, among the aqueous-
based structures, the lamellar architecture induced increased AP activity and demonstrated higher equi-
librium modulus than the spherical-pore scaffolds. Based on the collected data, we propose a conceptual
model describing the effects of silk scaffold design on bone tissue formation.
 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.1. Introduction
Numerous approaches have been made towards development
of an ‘‘ideal’’ scaffold for bone tissue engineering [1,2]. Silk ﬁbroin,
obtained from silkworms, demonstrates great biocompatibility
along with outstanding mechanical properties [3] and proteolytic
degradation [4]. In tissue engineering, silk ﬁbroin has been exten-
sively used for multiple types of scaffolds [5–8]. Various modiﬁca-
tions of silk scaffolds have been fabricated with a wide range of
chemical, structural and biomechanical modiﬁcations [6,9,10]. Silk
sponges have been used for cartilage [11–13] and fat [14,15], silk
tubes for blood vessels [16] and silk ﬁbers for ligaments [17,18].ia Inc. Published by Elsevier Ltd. A
Novakovic).Porous sponge scaffolds are suitable for bone tissue formation, as
they enhance cell attachment, proliferation and migration. In addi-
tion, the high porosity (92–98%) [19–21] facilitates nutrient and
waste transport into and out of the scaffolds.
Porous silk sponges can be fabricated using porogens, gas foam-
ing or lyophilization methods [22,23]. Among these, NaCl salt
leaching is one of the simplest and most effective fabrication meth-
ods, resulting in scaffolds with spherical pores and different mor-
phologies. Silk scaffolds are generally fabricated using two
different silk preparation methods: aqueous and solvent (hexa-
ﬂuoro-2-propanol; HFIP) based. HFIP does not solubilize salt parti-
cles, therefore pore sizes in these sponges reﬂect the size of the
porogen used in the process [22,23]. On the other hand, aqueous-
based silk sponges demonstrate pore sizes 10–20% smaller than
the size of salt crystals. This is due to partial solubilization of thell rights reserved.
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tion before solidiﬁcation [3,24]. This partial solubilization results in
rougher surfaces of the pores, which improved cell attachment
[22,25]. For comparison, aqueous-based processing results in
sponges with higher porosity [22,25] and higher degradation rates
[22,25].
Besides silk sponges with spherical pores, our laboratory devel-
oped a novel silk scaffold fabrication method to produce lamellar-
like structure using a freeze drying technique [26]. This structure
mimics bone lamellae structure. Human bone marrow mesenchy-
mal stem cells, cultured on osteogenic medium, attached, prolifer-
ated and assembled new extracellular matrix on this patterned
structure [26].
Tissue engineers have explored silk scaffolds for bone regener-
ation by using bone marrow mesenchymal stem cells (BM-MSC) as
the preferred cell source with superior outcomes validated with
both aqueous-based [19,26,27] and HFIP-derived scaffolds [6,21,
28]. Human adipose-derived stromal/stem cells (hASCs), on the
other hand, present features comparable to BM-MSC and are a
promising alternative for cell-based therapies [29] such as bone
tissue regeneration. hASCs may be easily isolated from adipose tis-
sue, with a high yield of cells per unit tissue volume [30]. Further-
more, hASCs proliferate quickly, and their osteogenic potential is
comparable to that of bone marrow mesenchymal stem cells
[31]. Our research group has engineered half-centimeter-sized
bone constructs in vitro by using hASCs that were seeded in decell-
ularized bone scaffolds and cultured dynamically in perfusion bio-
reactors [32].
Silk scaffold and hASCs are two potential components for bone
tissue engineering applications, which have not been yet investi-
gated in combination. In this study, ﬁve different scaffolds were
investigated: (i) aqueous, spherical-pore structure, small pores
(250–500 lm); (ii) aqueous, spherical-pore structure, large pores
(500–1000 lm); (iii) aqueous, lamellar structure; (iv) HFIP,medium
pore sizes (400–600 lm); and (v) decellularized bovine trabecular
bone,usedasa ‘‘gold standard’’, to evaluate theosteogenic responses
of hASCs and bone tissue development.2. Materials and methods
2.1. Preparation of silk ﬁbroin scaffolds
All chemicals were purchased from Sigma–Aldrich (St. Louis,
MO) unless otherwise stated. Silk scaffolds were prepared accord-
ing to Fig. 1. Silk ﬁbroin from silkworm (Bombix mori) cocoons was
extracted with 0.02 M sodium carbonate (Na2CO3) solution, rinsed
in distilled water, dissolved in a 9.3 M lithium bromide (LiBr) solu-
tion and dialyzed for 48 h against distilled water in benzoylated
dialysis tubing (Sigma D7884). Dissolved silk ﬁbroin was centri-
fuged for 20 min at 8600g (4 C). The resulting solution was deter-
mined by weighing the remaining solid after drying, yielding a
6 wt.% aqueous silk ﬁbroin solution.
Aqueous-derived silk ﬁbroin porous sponges were prepared by
salt leaching methods. NaCl salt was sieved with metal mesh to ob-
tain particle size distributions between 250 and 500 lm (Aq-250)
or between 500 and 1000 lm (Aq-500), and added into silk ﬁbroin
aqueous solution at a 2:1 (w/v) ratio, in disk-shaped containers.
The container was covered and left at room temperature. After
24 h, the container was immersed in water to extract NaCl salt
for 2 days, with 5–6 water changes per day.
Aqueous-derived silk ﬁbroin lamellar scaffolds (Aq-Lam) were
prepared by pouring silk ﬁbroin aqueous solution into silicon tub-
ing (6 mm i.d.), frozen at 80 C, lyophilized for 1 day, then auto-
claved to induce the formation of a b-sheet structure and
insolubility in aqueous solution.HFIP-derived silk ﬁbroin scaffolds (HFIP-400) were prepared as
previously described [25]. Silk ﬁbroin aqueous solution was lyoph-
ilized and further dissolved with HFIP, resulting in a 17 wt.%
HFIP-derived silk ﬁbroin solution. Granular NaCl particles (400–
600 lm)were added to 2 ml of silk ﬁbroin in HFIP at 2:1 (w/v) ratio.
The containers were covered overnight to reduce evaporation of
HFIP and to provide sufﬁcient time for homogeneous distribution
of the solution. Subsequently, the solvent was evaporated at room
temperature for 3 days. The matrices were then treated in 90 vol.%
methanol for 30 min, to induce the formation of the b-sheet struc-
ture, followed by immersion in water for 2 days to remove NaCl
porogens. Porous silk scaffolds were then freeze-dried. All scaffolds
were cut and cored into cylinders of 4 mm diameter and 2 mm
thickness.
2.2. Preparation of trabecular bone scaffolds
Trabecular bone scaffolds were decellularized as in our previous
studies [32,33]. Trabecular bone cylinders (4 mm diameter) were
cored from the subchondral region of carpometacarpal joints of bo-
vine calves and washed with a high-velocity stream of water to re-
move bone marrow from pore spaces. Scaffolds were further
washed for 1 h in phosphate-buffered saline (PBS) with 0.1% ethy-
lenediamine tetraacetic acid (EDTA) at room temperature (RT), fol-
lowed by sequential washes in hypotonic buffer (10 mM Tris and
0.1% EDTA) overnight at 4 C, in detergent (10 mM Tris and 0.5% so-
dium dodecyl sulfate) for 24 h at RT and in enzyme solution
(100 U ml1 DNAse, 1 U ml1 RNAse and 10 mM Tris) for 6 h at
37 C, to fully remove cellular material. Scaffolds were then rinsed
in PBS, freeze-dried and cut into 2 mm thick cylindrical plugs. The
scaffolds within the density range of 0.28–0.38 mg mm3 (calcu-
lated based on the dry weights and exact dimensions) were se-
lected for experiments.
2.3. Isolation, characterization and expansion of hASCs
hASCs were isolated according to previously described methods
[34] from liposuction aspirates obtained from the Pennington Bio-
medical Research Center, under protocols approved by the Institu-
tional Review Board. hASCs were expanded to the fourth passage in
expansion medium: high-glucose Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 10% fetal bovine serum
(FBS), penicillin–streptomycin (1%), and 1 ng ml1 basic ﬁbroblast
growth factor.
Passage zero (P0) cells were examined for surface marker
expression using ﬂow cytometry. The presence of speciﬁc antigens
such as CD29, CD105, CD45, CD34, CD44, CD73 and CD90 were
analyzed, as previously published [34,35]. hASCs were conﬁrmed
for their differentiation capacity into the adipogenic and osteo-
genic lineages in monolayer cultures following induction with adi-
pogenic and osteogenic inductive medium for up to 14 days and
histochemical analysis of neutral lipid (Oil Red O) or mineralization
(Alizarin Red) staining as published [36].
Three independent series of experiments were performed, each
with triplicates of samples for each experimental group, data point
and analytical method.
2.4. Construct seeding and culture
All scaffolds were sterilized in 70% ethanol overnight, washed in
PBS and incubated in expansion medium 24 h prior to seeding. For
construct seeding, expanded P4 hASCs were suspended in culture
medium at 3  107 cells ml1. Scaffolds were blot-dried, placed
individually into wells of a nontreated 12-well cell culture plate
and a 20 ll aliquot of cell suspension was pipetted into each scaf-
fold, and pipetted up and down to ensure even distribution of cells.
Fig. 1. Silk scaffold fabrication. Silk ﬁbroin is extracted from silkworm cocoons into an aqueous solution. Aqueous-based spherical-pore scaffolds (Aq-250 and Aq-500) are
produced by the salt-leaching method, where small (250–500 lm) or large (500–1000 lm) NaCl particles are used as the porogen. Aqueous-based lamellar scaffolds (Aq-Lam)
are produced by lyophilizing the frozen aqueous silk solution cast in a silicon tube. HFIP-derived porous scaffolds (HFIP-400) are developed by dissolving the lyophilized
aqueous silk solution in HFIP solvent, to which NaCl particles (400–600 lm) are added to form the porous structure. The NaCl particles used in the salt-leaching method are
further dissolved in water. Bold text represents the step where b-sheet formation occurs.
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10 ll of cell-free medium was added to maintain hydration. This
process was repeated four times to achieve uniform cell distribu-
tion, after which osteogenic medium (low-glucose DMEM, 10%
FBS, 1% penicillin–streptomycin, 10 mM sodium-b-glycerophos-
phate, 10 mM HEPES, 100 nM dexamethasone and 50 lg ml1
ascorbic acid-2-phosphate) was added. hASC-seeded scaffolds
were maintained in static culture (nontreated 12-well cell culture
plate) and nourished with 3 ml of osteogenic medium per well for
7 weeks to induce osteogenic differentiation of the stem cells and
to ensure robust bone tissue development.
2.5. Live/Dead assay
A Live/Dead Viability/Cytotoxicity Kit (Molecular Probes, OR,
USA) was used to evaluate cell viability. Live cells (indicated by cal-
cein AM) and dead cells (indicated by ethidiumhomodimer-1)were
observed and imaged through a confocal microscope (Leica, Ger-
many).Optical surfaceswere taken fromthe surface to160 lmdeep,
at 10 lm intervals. All images are presented as vertical projections.
2.6. Biochemical characterization
Constructs were harvested, washed in PBS, cut in half and
weighed. For DNA assay, half of the constructs were added to
1 ml of digestion buffer (10 mM Tris, 1 mM EDTA, 0.1% Triton X-
100, 0.1 mg ml1 proteinase K) and incubated overnight at 56 C
for digestion. After centrifugation at 3000g for 10 min, the superna-
tants were removed, diluted and pippeted in duplicate into a 96-
well plate. Picogreen solution (Quant-iT™ PicoGreen dsDNA Kit,
Invitrogen) was added to the samples in 1:1 ratio (v/v). Sample
ﬂuorescence was measured with a ﬂuorescent plate reader at an
excitation of 480 nm and an emission of 520 nm. LambdaDNA was used to prepare the standard curve. Based on previous
studies [32], 5 pg of DNA per cell was used as the conversion factor
to determine the cell number. For calcium quantiﬁcation, half of
the constructs were incubated in 1 ml of 5 vol.% trichloroacetic
acid and calcium was extracted by disintegrating the construct
using steel balls and a MinibeadBeaterTM (Biospec, Bartlesville,
OK, USA). The calcium content and standard were quantiﬁed using
StanbioTotal Calcium Liquicolor (Stanbio Laboratory, USA). The
sample’s optical density was measured at 575 nm using a micro-
plate reader. Alkaline phosphatase (AP) activity was determined
by adding cell lysis solution to half of each scaffold, which were
then disintegrated using steel balls and a MinibeadBeaterTM. After
centrifugation, 50 ll of supernatant was incubated with 50 ll of p-
nitrophenyl-phosphate (pNPP) substrate solution at 37 C for
20 min. The reaction was stopped with 50 ll of stop solution,
and the absorbance was read at 405 nm. p-Nitrophenol at known
concentrations was used to prepare the standard curve. All solu-
tions were components of the SensoLyte pNPP Alkaline Phospha-
tase Complete Kit (Cell Biolabs, CBA-302).
2.7. Histology and immunohistochemistry
After harvest, the samples were ﬁxed in 4% formaldyhyde solu-
tion for 1 day. Bone scaffolds were decalciﬁed with immunocal
solution (Decal Chemical, Tallman, NY) for 1 day and further dehy-
drated with graded ethanol washes, concurrently with the rre-
maining silk constructs. Samples were embedded in parafﬁn,
sectioned in 5 lm slices and mounted on glass slides. For staining,
sections were deparafﬁnized with CitriSolv and rehydrated with a
graded series of ethanol washes. Samples were stained using stan-
dard hematoxylin and eosin (H&E) staining. Immunohistochemis-
try was performed on sections as follows: sections were blocked
with normal horse serum (NHS), stained sequentially with primary
2486 C. Correia et al. / Acta Biomaterialia 8 (2012) 2483–2492antibody (rabbit anti-human osteopontin (OPN) polyclonal anti-
body, Chemicon ab1870; rabbit anti-bone sialoprotein (BSP) poly-
clonal antibody, Millipore ab1854; mouse monoclonal anti-collagen
I, Abcam ab6308; NHS for negative control) and secondary antibody
(Vectastain Universal Elite ABC Kit, PK-6200 Vector Laboratories), and
developed with a biotin–avidin system (DAB Substrate Kit SK-4100,
Vector Laboratories).
2.8. Microcomputed tomography (lCT) analysis
Before culture, the architecture of the silk scaffolds was evalu-
ated using a micro-CT Skyscan 1072 scanner (Skyscan, Kontich,
Belgium). The X-ray scans were acquired in high-resolution mode
with a pixel size of 8 lm, an integration time of 1.3 s, and penetra-
tive X-rays of 35 keV and 209 lA. Data sets were reconstructed
using standardized cone–beam reconstruction software (NRecon
v1.4.3, SkyScan). A representative data set of the slices was seg-
mented into binary images with a dynamic threshold of 40–255
(grey values), which were used for morphometric analysis (CT Ana-
lyser, v1.5.1.5, SkyScan) and to build three-dimensional (3-D) mod-
els (ANT 3D creator, v2.4, SkyScan).
After culture, lCT was performed using the protocol described
by Liu et al. [37]. Samples were aligned in a 2 ml screw-cap centri-
fuge tube, which was clamped in the specimen holder of a vivaCT40
system (SCANCO Medical AG, Basserdorf, Switzerland). The 2 mm
length of the scaffold was scanned at 21 lm isotropic resolution.
A global thresholding technique, which only detects mineralized
tissue, was applied to obtain the bone volume (BV) of the samples.
2.9. Scanning electron microscopy (SEM)
Samples were washed in PBS and then ﬁxed in 2% glutaralde-
hyde in sodium cacodylate buffer for 2 h. Constructs were washed
in buffer and freeze-dried overnight. The samples were coated with
gold and palladium and imaged in machine scanning electron
microscope (JEOL, Japan).
2.10. Mechanical testing
Young’s modulus upon compression of constructs after culture
was determined under unconﬁned compression in wet conditions
using a modiﬁcation of an established protocol [38]. An initial tare
load of 0.2 N was applied and was followed by a stress–relaxation
step, where specimens were compressed at a ramp velocity of 1%
s–1 up to 10% strain and maintained in that position for 1800 s. The
Young’s modulus was obtained from the equilibrium forces mea-
sured at 10% strain.
2.11. Statistical analysis
Data are presented as mean (three independent series of exper-
iments, each with n = 3 per group, data point and analytical
assay) ± standard deviation. Statistical signiﬁcance was deter-
mined using analysis of variance followed by Tukey’s HSD (hon-
estly signiﬁcant difference) test using Prism software (Prism 4.0c,
GraphPad Software Inc.).
3. Results
3.1. Characterization of undifferentiated hASCs
The immunophenotype of undifferentiated hASCs was evalu-
ated using ﬂow cytometry (Fig. 2A). The antigen expression proﬁle
observed was consistent with our previous study [39]: expression
of the adhesion molecules integrin b1 (CD29) and endoglin(CD105), high expression of ecto 50-nucleotidase (CD73) surface
enzyme as well as extracellular matrix proteins such as Thy-1
(CD90) and glycoprotein CD34. Hyaluronate (CD44) receptor mol-
ecule was expressed to a lesser degree than expected; however,
expression of hematopoietic marker CD45 was accordingly very
low. Multilineage potential of hASCs was evaluated by cultivation
of cell monolayers in adipogenic or osteogenic medium. The iso-
lated hASCs exhibited multi-lineage differentiation, as shown with
the formation of Oil Red O staining lipid droplets (Fig. 2C) and Aliz-
arin Red staining extracellular mineralization (Fig. 2D).
3.2. Characterization of silk ﬁbroin scaffolds
The architecture of the aqueous-based silk ﬁbroin scaffolds was
characterized by SEM and lCT analysis (Fig. 3). Both SEM imaging
(Fig. 3, top) and lCT 3-D reconstructions (Fig. 3, middle) demon-
strate the pore morphology of the developed structures. Spherical
interconnected pores, forming a trabecular-like network, are ob-
served in the Aq-250 and Aq-500 groups, fabricated by the salt-
leaching method with two ranges of porogen size (250–500 and
500–1000 lm, respectively). On the other hand, Aq-Lam presents
a structure where the pore walls do not form a sphere, but form
parallel lamellae, which are aligned in several directions within
the 3-D structure.
Porosity, interconnectivity, pore size and trabeculae thickness
were obtained by lCT analysis (Fig. 3, bottom): the Aq-500 struc-
ture presents the highest porosity value (86.62 ± 0.84%) and high-
est average pore size (254.32 ± 13.64 lm), which is explained by
the use of bigger NaCl particles. The highest percentage of inter-
connectivity (97.83 ± 0.61%) was also measured for this group.
Characterization of the Aq-Lam demonstrated a more compact
structure, with lower porosity (64.25 ± 8.82%) and smaller pore
size (126.24 ± 48.16%), and 35% less pore interconnectivity
(63.25 ± 21.13%) than Aq-500.
3.3. Cell viability and proliferation
Cell seeding efﬁciency, calculated as a fraction of the initial cells
detected in the scaffold after seeding, ranged from 60% to 75% in all
ﬁve groups, without statistically signiﬁcant differences (Fig. 4A).
DNA assay (Fig. 4B) demonstrated that, after 2 weeks of culture,
proliferation occurred to the same extent (an approximately 1.6-
fold increase in cell numbers) in all spherical porous silk sponges,
whether aqueous or HFIP based (Aq-250, Aq-500, HFIP-400). In
contrast, the lamellar structure maintained the initial cell numbers
throughout the culture period. In aqueous scaffolds, the cell num-
bers achieved by week 2 were maintained through week 7. In the
HFIP scaffold group, the cell number increased continuously. In the
decellularized bone group, the cell number decreased at the end of
the culture period. The Live/Dead assay conﬁrmed the cell viability
and attachment throughout all the scaffolds (Fig. 4C).
Good distribution of cells at the periphery and center of the con-
structs was observed through H&E staining in all groups (Fig. 5
top). Cells attached to scaffold surfaces, and ﬁlled the pore spaces.
Rough pore surfaces were observed by H&E staining (Fig. 5 top)
and SEM (Fig. 5 middle and bottom) in aqueous spherical-pore
scaffolds, in contrast to smooth pore surfaces in HFIP scaffolds.
The matrix density appeared to be greater in the aqueous porous
scaffolds (Aq-250 and Aq-500) and the trabecular bone scaffold
than in the HFIP-derived scaffolds.
3.4. Bone tissue development
Distribution of bone tissuematrixwas evaluated through immu-
nolocalization of bone matrix proteins after 7 weeks of culture in
osteogenic medium. The expression of OPN, BSP and collagen type
Fig. 2. Phenotypic characterization and evaluation of the multipotency of human adipose stem cells. (A) Percentage of antigen expression in primary hASCs. (B) Toluidine
blue staining of undifferentiated stromal cells. (C) Oil Red O staining for adipogenesis. (D) Alizarin Red staining for osteogenesis.
Fig. 3. Aqueous-based silk ﬁbroin scaffolds characterization. Top row: SEM images of Aq-250, Aq-500 and Aq-Lam scaffolds, demonstrating pore morphology and wall
surface. Scale bar = 500 lm. Middle row: lCT 3-D reconstruction of silk ﬁbroin scaffolds. Bottom row: morphometric parameters obtained by lCT analysis.
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size aqueous silk sponges (Fig. 5). These bone matrix markers were
distributed throughout the decellularized bone scaffold. The most
robust groupswere the aqueous lamellar andHFIP-derived sponges,
with high intensities of immunolocalization of OPN and BSP, and a
somewhat lower intensity of Col I. The cells maintained their
osteogenic properties throughout the duration of culture.
3.5. Quantiﬁcation of bone differentiation parameters
To complement the immunostains shown in Fig. 5, quantita-
tive biochemical data were obtained to determine the amounts
of bone differentiation markers. AP activity, an early marker of
osteoblastic phenotype, peaked after 2 weeks of culture, as ex-
pected, at similar levels in all groups, except for signiﬁcantlyhigher expression in the Aq-Lam group (Fig. 7A). As an indicator
of extracellular matrix (ECM) maturation and calciﬁcation, AP
activity levels decreased by 7 weeks of culture. The calcium depo-
sition increased in parallel to the decrease in AP activity, between
weeks 2 and 7, with signiﬁcantly higher levels in HFIP and decell-
ularized bone scaffolds than in other groups (Fig. 7B). Consistent
with the biochemically measured calcium levels, the BV detected
by lCT analysis was also higher in the HFIP than in the aqueous
scaffolds, and was highest in the decellularized bone group (Fig
7C). Although not signiﬁcantly different, HFIP-derived sponges
(HFIP-400) demonstrated an increased bone volume relative to
the aqueous-based groups. The equilibrium modulus of the con-
structs was also highest for the decellularized bone group, and
higher for the HFIP than the aqueous spherical-porous scaffolds
(Fig. 7D). Interestingly, the aqueous-based silk ﬁbroin lamellar
Fig. 4. Cell viability and proliferation. (A) Cell seeding efﬁciency. No signiﬁcant differences were observed between groups. (B) Cell proliferation evaluated by changes in the
number of cells per scaffold. ⁄p < 0.05, ⁄⁄p < 0.01, ⁄⁄⁄p < 0.001; (a) p < 0.05, (b) p < 0.01, (c) p < 0.001 to Aq-Lam; (d) p < 0.05 to Aq-250 and HFIP-400; (e) p < 0.05 to Aq-500 and
HFIP-400; (C) cell viability (Live/Dead assay) after 7 weeks of culture. Scale bar = 200 lm.
Fig. 5. Scaffold structure. Constructs were analyzed after 7 weeks of culture. Top row: H&E staining, scale bar = 200 lm. Middle row: SEM images, 50, scale bar = 500 lm.
Bottom row: SEM images, 400, scale bar = 50 lm.
2488 C. Correia et al. / Acta Biomaterialia 8 (2012) 2483–2492structure (Aq-Lam) was threefold stiffer than the corresponding
aqueous-based porous silk sponges (Aq-250 and Aq-500)
(p < 0.01). This is evidence of the importance of the scaffold archi-
tecture for the resulting mechanical properties of the engineered
tissue. Furthermore, the mineralized tissue was better distributed
in the HFIP-400 group (Fig. 7E), where small sphere-like struc-
tures were observed, whereas in the aqueous groups mineral
was deposited less uniformly throughout the construct, forming
plate-like structures.4. Discussion
In this study, we investigated different types of silk-based scaf-
folds by various fabrication methods, as a potential material of
choice for bone tissue engineering applications [19,26], with focus
on hASCs as a cell source. Notably, the hASCs showed expression
patterns of surface markers characteristic for mesenchymal stem
cell (CD105+, CD73+, CD90+, CD45, CD44) (Fig. 2A) consistent
with that of the BM-MSCs, which have been successfully used for
Fig. 6. Accumulation of bone matrix proteins in tissue constructs. Data are shown after 7 weeks of culture. Top row: OPN; middle row: BSP; bottom row: Col I. Scale
bar = 100 lm.
C. Correia et al. / Acta Biomaterialia 8 (2012) 2483–2492 2489engineering of bone [40]. The multi-lineage differentiation capabil-
ity (adipogenic and osteogenic) was also veriﬁed and similar to
that observed for BM-MSCs (Fig. 2B–D). Our previous studies con-
ﬁrmed the maintenance of a high level of expression of the surface
markers for hASC stemness and differentiation capability over sev-
eral passages [32].
Four different types of silk scaffolds were investigated. Aque-
ous-based silk ﬁbroin sponges were produced with three distinct
pore sizes and morphologies: the Aq-250 structure had an aver-
age porogen size of 375 lm, which has been accepted as the
optimal pore size for bone formation [41]; Aq-500 aimed at
resembling the pore size of native trabecular bone [42]; and
Aq-Lam resembled the lamellar microstructure of bone [26]. In
addition to aqueous-based scaffolds, HFIP-400, another silk scaf-
fold, which has previously demonstrated rapid bone formation
when cultured with BM-MSCs, was also studied [21]. While the
Aq-250, Aq-500 and HFIP-500 groups present a spherical pore
formed by salt leaching, the Aq-Lam group presents a structure
where the pore walls form parallel lamellae, which are aligned
in several directions (Fig. 3). Decellularized trabecular bone
was used as a ‘‘gold standard’’. The hASC osteogenic activity
and bone formation among the different scaffolds were directly
compared.
The differences in the silk scaffolds due to their preparation
methods did not affect the hASC seeding efﬁciency (Fig. 4A), sug-
gesting insigniﬁcant effects of solvent used and pore morphology
on hASC attachment. After cultivation for 7 weeks, cell numbers in-
creased in all groups except Aq-Lam (Fig. 4B). The data suggest that
cells have limited available space to proliferate once porosity, pore
size and interconnectivity (Fig. 3, bottom) are signiﬁcantly inferior
to those of aqueous-derived scaffolds with spherical pores (Aq-250
and Aq-500). The seeding efﬁciency in Aq-Lam group was not infe-
rior to that of the other groups, which may indicate that cells were
efﬁciently seeded in the structure, and might have become satu-
rated, limiting cell proliferation and stimulating cell differentia-
tion. Both Aq-250 and Aq-500 did not demonstrate a signiﬁcant
difference regarding proliferation, which can be explained by con-
tact inhibition [43]. Contrarily, the proliferation data of HFIP-400
show that there was a continuous increase throughout the culture
period, but the cell numbers at the end of culture were no higher
than in the other spherical-pore silk structures (Aq-250 andAq-500). It seems that the cells proliferated at a slower rate, which
can be explained by the scaffold’s smoother pore surfaces, as has
been reported elsewhere [3].
Over 7 weeks, hASCs differentiated and expressed osteogenic
markers in all groups, albeit with different intensities. Bone tissue
development for aqueous-based scaffolds, both small and large
pore size (Aq-250 and Aq-500), was found to be similar. Pore size
did not inﬂuence seeding efﬁciency or cell proliferation. Cell viabil-
ity, morphology (Fig. 4C) and distribution throughout individual
pores or across the entire scaffold were very similar between the
two groups (Fig. 5, top). Bone proteins, such as OPN, BSP and Col
I, were produced and retained in the form of extracellular matrix
to an analogous extent (Fig. 5). In addition, pore size did not affect
the amount of P production, calcium deposition or bone volume.
The equilibrium moduli of Aq-250 and Aq-500 were also similar.
We postulate that, while smaller pores promote increased the
mechanical strength, the larger pores were associated with a more
homogeneous matrix [25] – characteristics which may compensate
the compressive capacity. Of the four silk scaffold groups in this
study, Aq-250 and Aq-500 were inferior.
Lamellar aqueous-based silk ﬁbroin scaffolds (Aq-Lam) showed
some interesting features. The equilibrium modulus was the high-
est among all silk scaffold groups at the beginning of culture, which
might be due to the small inter-lamellar distance (25–100 lm), but
also demonstrated the most signiﬁcant increase in mechanical
properties after culture (p < 0.01) (Fig. 7D). This reﬂects the signif-
icant calcium increase observed in this group (p < 0.05) (Fig. 7B),
and the increased deposition of bone proteins such as OPN, BSP
and Col I (Fig. 6). Furthermore, the cells of the Aq-Lam group ex-
pressed the most AP activity at week 2 of culture (Fig. 7A), showing
enhancement of osteogenic differentiation. Absolute values of cal-
cium change and bone volume (Fig. 7B and C), though, were similar
to those observed for Aq-250 and Aq-500 groups. This result is not
surprising, as the native lamellar bone is generated more slowly
than woven bone and is less mineralized [44].
Out of the four silk scaffold groups, the HFIP-derived sponge sup-
ported themost hASC osteogenic induction and bone-like tissue for-
mation. The similarity of cell proliferation and morphology to
aqueous-based scaffolds demonstrated that the higher silk concen-
tration andHFIP solvent did not alter the abilities of hASCs to adhere
and proliferate. However, HFIP-derived scaffolds enhanced hASC
Fig. 7. Biochemical and mechanical characterization of constructs. (A) AP activity: ⁄p < 0.001; (a) p < 0.05, (b) p < 0.01 to Aq-250; (c) p < 0.05 to Aq-Lam; (d) p < 0.05, (e)
p < 0.01, (f) p < 0.001 to bone; (g) p < 0.05 to HFIP-400. (B) Calcium change from day 1 measured at 2 and 7 weeks of culture: ⁄p < 0.05, ⁄⁄p < 0.01, ⁄⁄⁄p < 0.001; (a) p < 0.05, (b)
p < 0.01 to bone. (C) BV of constructs at week 7: #p < 0.05 to bone. (D) Equilibrium modulus at the beginning and end of culture: ⁄p < 0.05, ⁄⁄p < 0.01; (a) p < 0.05 to HFIP-400,
(b) p < 0.001 to Aq-Lam, (c) p < 0.001 to HFIP-400 and Aq-Lam, (d) p < 0.001 to all other groups. (E) lCT Reconstruction images of constructs after 5 weeks of culture. Scale
bar = 1 mm.
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ization, quantiﬁed by calcium retention in the scaffold (Fig. 7B) and
mineralized BV (Fig. 7C). According to lCT reconstruction of cul-
tured constructs (Fig. 7E), mineral was evenly distributed through-
out the scaffold in this group, showing homogeneous osteogenic
activity of hASCs. Regarding mechanical properties, although the
equilibrium modulus of HFIP-based silk scaffold was higher than
aqueous-based constructs with spherical pores even from the
beginning of culture, possibly due to the higher concentration of silk
material (Fig. 7D), among these three groups, HFIP-400was the only
group demonstrating a signiﬁcant increase in mechanical proper-
ties from the beginning to the end of culture (p < 0.05). This can
be justiﬁed by the deposition of a more robust ECM, composed of
both ECM proteins and calciﬁcation, as discussed above.
Decellularized trabecular bone scaffolds have been used suc-
cessfully in bone tissue engineering studies [32,33,45]. Although
the bone-forming structure and mechanical properties of the silk
scaffolds were inferior to the trabecular bone scaffold, the osteo-
genic cellular activities in the Aq-250 and Aq-500 groups were
similar to the bone scaffold and were enhanced in the Aq-Lam
and HFIP-400 groups (Figs. 6 and 7A).
Taken together, the data collected in this study are consistent
with the conceptual model shown in Fig. 8. Two distinguishable
scaffold properties – scaffold architecture and mechanical stiffness– appear to affect bone formation (Fig. 8). First, scaffold stiffness is
positively correlated with osteogenic differentiation of hASCs,
resulting in an increase in bone ECM secretion (Fig. 8A). The impor-
tance of mechanical properties in bone tissue engineering has been
well established [19,46]. Similar to previous ﬁndings, HFIP-derived
silk ﬁbroin scaffolds, which exhibited higher stiffness as compared
to aqueous-based silk ﬁbroin scaffolds, appear to provided a better
platform for bone formation. Second, the scaffold structure appears
to alter cellular activities as well as bone tissue formation. A porous
lamellar morphology is postulated to beneﬁt hASC osteogenic dif-
ferentiation into lamellar bone, which contains fewer cells but has
higher mechanical properties once it is highly organized, while a
spherical porous structure leads to the development of woven
bone, which contains higher cellularity and mineral density but
is far less organized (Fig. 8B) [44,47].
Based on the extensive work already reported on bone tissue
engineering with BM-MSC on silk scaffolds and the data we pres-
ent in this study, we speculate that hASC are a good alternative cell
source to BM-MSC for bone TE. For instance, our research group has
reported the outcomes of engineered bone grafts by culturing BM-
MSC in similar HFIP scaffolds up to 5 and 10 weeks [6], and, even
when culturing in dynamic conditions by ﬂow perfusion, bone-re-
lated outcomes were less patent than those obtained in the present
study.
Fig. 8. Proposed mechanism of regulation of bone formation by scaffold architecture and stiffness. (A) Scaffold mechanics. Mechanically stronger HFIP-derived silk scaffolds
promote osteogenic differentiation of hASCs to result in increased BV, calcium content and bone protein deposition, as compared to aqueous-based scaffolds. (B) Scaffold
architecture. A sponge-like architecture with spherical pores serves as a template for the formation of woven bone, while a lamellar porous architecture serves as a template
for the formation of lamellar bone.
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This study has demonstrated the optimization potential of silk
scaffolds in terms of structure (porosity, pore dimensions and pore
geometry) and biomechanics for bone tissue engineering applica-
tions. We have demonstrated that human adipose-derived stem
cells interpret the extracellular environment, by responding differ-
ently to the architecture of silk scaffolds and producing bone-like
extracellular matrix in a manner that appears to depend on the
structure and stiffness of the scaffolds. Based on the collected data,
we have proposed a conceptual model that correlates bone tissue
formation with the architecture and stiffness of silk scaffolds,
which emphasizes the importance of appropriate scaffold design
when engineering bone.
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